Manage episode 364202704 series 3360496
200,000 men at diagnosed each year with Prostate cancer … beginning a journey of many successive treatments. Still, 35,000 men die as a result of prostate cancer. Convergent Therapeutics is focusing on the most advanced, intractable cases of prostate cancer. We speak with, Dr. Philip Kantoff is its Co-Founder, Chief Medical Officer and CEO.